Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page
- Check7 days agoChange DetectedA new site revision entry, v3.6.2, was added to the changelog while the previous entry, v3.6.0, was removed, indicating a software/version update rather than a modification to the study details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now includes a recruitment status update 'No longer looking for participants.' It adds new guidance sections 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' and the revision note updates from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check29 days agoChange DetectedRevision tag changed from v3.5.4 to v3.5.5, indicating a minor update to the page metadata. This update does not appear to modify the study content or user-facing information.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a software version update for the site. This change does not modify the displayed study content or its results.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a change to the site build rather than the clinical trial information shown to users.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.